Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens

scientific article published on October 2006

Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.177.8.5490
P698PubMed publication ID17015735
P5875ResearchGate publication ID6778824

P50authorDavid W DunneQ30513910
Klaudia WalterQ37371637
Birgitte J VennervaldQ41047434
Narcis B KabatereineQ56762863
Joseph K MwathaQ115100940
Gachuhi KimaniQ115100943
P2093author name stringSarah Joseph
Frances M Jones
Anthony J C Fulford
John H Ouma
H Curtis Kariuki
Rowena McBeath
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectSchistosoma mansoniQ2324689
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)5490-5498
P577publication date2006-10-01
P1433published inJournal of ImmunologyQ3521441
P1476titleIncreased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens
P478volume177

Reverse relations

cites work (P2860)
Q80290782Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis
Q28541675An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas
Q28475501Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE
Q35088439Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil
Q62486477Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
Q35751348CD4+CD25hiFOXP3+ Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel
Q24657733Current status of vaccines for schistosomiasis
Q38853774DEWORMING DELUSIONS? MASS DRUG ADMINISTRATION IN EAST AFRICAN SCHOOLS.
Q34500892Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray
Q53697118Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.
Q33419492Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial
Q37627668Effects of maternal worm infections and anthelminthic treatment during pregnancy on infant motor and neurocognitive functioning
Q36506153Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections
Q34413522Human schistosomiasis
Q35000247Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour
Q37191336Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.
Q34782228Immunology of human schistosomiasis
Q33611746Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases
Q37464180Longitudinal analysis of antigen specific response in individuals with Schistosoma mansoni infection in an endemic area of Minas Gerais, Brazil
Q36010705Multivariable Regression Analysis in Schistosoma mansoni-Infected Individuals in the Sudan Reveals Unique Immunoepidemiological Profiles in Uninfected, egg+ and Non-egg+ Infected Individuals
Q37994231Parasite glycans and antibody-mediated immune responses in Schistosoma infection
Q64443565Population level changes in schistosome-specific antibody levels following chemotherapy
Q33596079Posttreatment changes in cytokines induced by Schistosoma mansoni egg and worm antigens: dissociation of immunity- and morbidity-associated type 2 responses
Q36396801Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis?
Q34654313Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils
Q56909282S. mansoni Schistosomula Antigens Induce Th1/Proinflammatory Cytokine Responses
Q61415127Schistosoma mansoni schistosomula antigens induce Th1/Pro-inflammatory cytokine responses
Q35130094Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection
Q34249973Suppression of basophil histamine release and other IgE-dependent responses in childhood Schistosoma mansoni/hookworm coinfection
Q60949688Systemic Cytokine and Chemokine Profiles in Individuals With Infection and Low Parasite Burden
Q37014921T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment
Q57152572The Interdependence between Schistosome Transmission and Protective Immunity
Q38871350Understanding ethnic differences in behaviour relating to Schistosoma mansoni re-infection after mass treatment

Search more.